Seems like people who've been using the technology on the DL don't want to see its commercialization.
ENGADGET: Star38.com death threats
Girardi said things would be different if Granderson wasn't on the DL for his second time this season.
WSJ: Yanks' Pettitte back from DL, Overbay in RF
Merck announced today that the HPS2-THRIVE ( H eart P rotection S tudy 2- T reatment of H DL to R educe the I ncidence of V ascular E vents) study did not meet its primary endpoint.
FORBES: HPS2-THRIVE: No Benefit, Signal Of Harm For Niacin Therapy
应用推荐
模块上移
模块下移
不移动